KOSDAQIT & Software411080

Sands Lab

₩5,410▲ 3.84%2026-11-18 close
Market Cap
₩82.6B
Turnover
₩4.4B
Volume
770K
Shares out.
15.3M
PER
—
PBR
1.6×
EPS
-₩117
Dividend Yield
0.00%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩0 per share · Prices as of the 2026-11-18 close

01

Report overview

Sands LAB: Q4-Weighted Revenue and the Japan Export Test

Sands LAB's annual revenue recovered to KRW 11.6 billion in 2025, but operating losses have continued through the first three quarters of 2026 in a business where sales cluster in the fourth quarter, so whether Japan export revenue shows up in reported results is the next point to confirm.

  1. 1

    Operating results were in the red for three consecutive years from 2023 to 2025, with the 2025 operating loss narrowing to KRW 1.77 billion from KRW 3.71 billion in 2024.

  2. 2

    Fourth-quarter 2025 revenue reached KRW 6.39 billion against KRW 802 million in the prior quarter, and operating profit of KRW 2.53 billion marked a return to the black.

  3. 3

    Quarterly revenue has fallen for three straight quarters from the first quarter of 2026 through the third, and the attributable net loss over the latest four quarters totals KRW 1.81 billion.

  4. 4

    The Japan export of MNX units and the move of the C-Brain government project into its main phase were cited as 2026 growth drivers in a January 2026 press report.

  5. 5

    Total equity at the end of 2025 stood at KRW 54.3 billion with a debt ratio of 6.9%, and a cash dividend was approved at the March 2026 shareholder meeting, the first since the company listed.

02

Business structure

Sands LAB is a cyber threat intelligence (CTI) specialist that supplies intelligence products used to anticipate and respond to cyber threats. Its main revenue has been generated from CTI product sales, although the reported revenue mix differs by source.

A financial information site put product sales at 99.47% and SI (system integration) at 0.53% as of late September 2026, while a press report on the first nine months of 2025 showed CTI revenue of KRW 1.009 billion and SI revenue of KRW 4.216 billion.

The different aggregation bases make a firm segment split difficult to establish. In SI, the company won the government's C-Brain project, a cybersecurity-focused generative AI build, as part of a consortium with PersonaAI.

The 2025 pilot was about KRW 5 billion, and the project was reported to move into its main phase in 2026 with a scale of KRW 15 billion.

Overseas, the company signed an export deal with a Japanese local distributor covering 1,000 units of MNX, its cloud and lightweight product, with annual production of roughly 4,000 units and further supply contracts reported as planned.

The company positions the export of its network detection and response (NDR) solution to Japan as a medium-term growth pillar. Its 2026 corporate value enhancement plan sets out technology competitiveness, profit-focused management, and R&D capability as core goals.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩800M-₩1.5B−181.0%
2025Q4₩6.4B₩2.5B39.7%
2026Q1₩1.8B-₩1B−55.2%
2026Q2₩1.5B-₩900M−56.0%
2026Q3₩1.2B-₩1.3B−108.3%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩9.3B₩2.1B₩2.2B22.5%107.8%389.2%
2023₩11.7B-₩900M₩400M−7.5%1.1%14.1%
2024₩8.3B-₩3.7B-₩2.3B−44.7%−4.8%5.7%
2025₩11.6B-₩1.8B-₩500M−15.2%−1.0%6.9%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-17

04

Earnings analysis

Annual revenue rose from KRW 9.3 billion in 2022 to KRW 11.7 billion in 2023, up 26.0% year on year, fell to KRW 8.3 billion in 2024, down 29.2%, and recovered to KRW 11.6 billion in 2025, up 40.0%. Among the years from 2022 to 2025, 2023 was the largest and 2024 the smallest.

Operating profit of KRW 2.09 billion in 2022 turned into an operating loss of KRW 884 million in 2023, which widened to KRW 3.71 billion in 2024 before narrowing to KRW 1.77 billion in 2025. The operating margin moved from 22.5% in 2022 to -7.5% in 2023, -44.7% in 2024 and -15.2% in 2025.

Operating and net results moved in different directions in some years; in 2023 attributable net income of KRW 439 million stood against an operating loss, which points to non-operating items affecting the bottom line.

In 2025 the net loss including non-controlling interests was KRW 465 million, while the attributable net loss was KRW 550 million, so the two figures should be read separately.

Operating cash flow swung from KRW 3.53 billion in 2022 to -KRW 8.03 billion in 2023 and then -KRW 212 million in 2024, before turning to KRW 325 million in 2025.

On a quarterly basis, revenue climbed from KRW 802 million in the third quarter of 2025 to KRW 6.39 billion in the fourth quarter, up 696.0% from the prior quarter, when operating profit of KRW 2.53 billion and an attributable net income of KRW 1.49 billion marked a return to profit.

Press coverage noted that CTI revenue typically concentrates in the fourth quarter. In 2026, revenue fell for three straight quarters, to KRW 1.83 billion in the first quarter (down 71.4% from the prior quarter), KRW 1.55 billion in the second and KRW 1.21 billion in the third.

Operating losses were KRW 1.01 billion in the first quarter, KRW 866 million in the second and KRW 1.31 billion in the third.

05

Industry analysis

The market Sands LAB serves is seeing cyber threats grow alongside the spread of AI, and companies adopting AI are creating new security demand. Press coverage interpreted these expectations as already reflected in the share price.

A report also highlighted that Nvidia's chief executive named cybersecurity as a next growth market for AI, which was cited as a driver of investor sentiment. In September 2026, the stock rose more than 20% in a single session on the AI security theme, a move that underscored its trading as a thematic stock.

Demand in the security sector follows the timing of security budgets at companies and public agencies, and Sands LAB's revenue shows a pattern of concentrating in the fourth quarter, when those budgets tend to be spent.

Ahnlab is a listed security peer in the same industry, while Sands LAB focuses on the specific CTI segment. CTI analysis of threat intelligence differs from general security products in that it blends product sales with build-out projects.

The C-Brain project serves as an example of public security demand translating into a product and project flow. Japan has emerged as a new overseas market, and how fast export contracts are recognized as revenue is a company-specific variable separate from the sector cycle.

Even with a supportive industry backdrop, quarterly results can swing widely depending on the timing of revenue recognition and contract delivery.

06

Outlook

On May 13, 2026, the company disclosed its 2026 corporate value enhancement plan, setting out technology competitiveness, profit-focused management and R&D capability, along with continued execution of its shareholder return policy. Three business items have been reported.

First, the C-Brain government project was reported to expand from a pilot of about KRW 5 billion in 2025 to a main-phase scale of KRW 15 billion in 2026. Second, the Japan supply volume signed in 2025 was reported to be recognized as revenue from 2026, with further second and third supply contracts planned.

Third, an analyst at a securities firm said in a January 2026 report that revenue from Japan was expected to drive an improvement in results.

That outlook dates from January 2026, and the quarterly revenue disclosed for the first three quarters of 2026 declined, so whether the Japan volume and the main-phase conversion have reached quarterly results is not yet confirmed. No annual revenue guidance from the company was identified.

The next periodic report is the 2026 annual report, which will first disclose fourth-quarter 2026 results and the full-year figures. After that, the first-quarter 2027 report will show whether Japan revenue is reflected in quarterly sales. Continuity of the dividend will be confirmed through the shareholder resolution.

07

Valuation

PER
—
PBR
1.6×
ROE
-3.6%
EPS
-₩117
BPS
₩3,169
Dividend per share
₩0

Because the company has posted net losses over the latest four quarters, its price-to-earnings ratio cannot be calculated, which leaves the price-to-book ratio as the main comparison point. The price-to-book ratio is above 1 times, meaning the share price sits above book value.

Attributable equity accounts for KRW 54 billion of the KRW 54.3 billion total equity, so most of the equity belongs to shareholders of the parent. A debt ratio of 6.9% keeps financial leverage risk limited.

The dividend was approved for the first time since listing, in the settlement for fiscal 2025, and reads as a signal of shareholder return commitment while earnings remain unstable.

The multi-year trend shows a move from profit in 2022 through losses to a narrower loss in 2025, with the operating margin improving in direction. Quarterly operating losses continued through 2026, so whether a return to sustained profit is taking hold remains unconfirmed.

The valuation reading depends on how quickly earnings recover and how fast Japan revenue shows up in the numbers.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-17

08

Bull factors

Japan export pipeline

A Japanese local distributor signed an export contract covering 1,000 MNX units, with annual production reported at around 4,000 units. Further second and third supply contracts were reported as planned.

An analyst at Kiwoom Securities said in a January 2026 report that Japan revenue was expected to drive an improvement in results.

Government project could expand SI revenue

The company won the C-Brain project, a government cybersecurity-focused generative AI build, through a consortium, and the main phase was reported to expand to KRW 15 billion in 2026. A press report said SI revenue for the first nine months of 2025 already exceeded the full-year 2024 SI revenue of KRW 2.8 billion. Public-sector security demand adds a revenue axis alongside product sales.

Narrowing losses and a fourth-quarter return to profit

The 2025 operating loss narrowed to KRW 1.77 billion from KRW 3.71 billion in 2024, and the fourth quarter of 2025 delivered operating profit of KRW 2.53 billion, a return to the black. Operating cash flow also turned from -KRW 8.03 billion in 2023 to KRW 325 million in 2025. The narrowing loss trend points to a path toward earnings recovery.

09

Bear factors

Quarterly losses continue into 2026

Operating losses ran for three straight quarters in 2026, at KRW 1.01 billion in the first quarter, KRW 866 million in the second and KRW 1.31 billion in the third. The third-quarter loss widened from the prior quarter.

The attributable net loss over the latest four quarters totals KRW 1.81 billion, and whether profitability holds is not yet confirmed.

Revenue concentrated in the fourth quarter and volatile

Fourth-quarter 2025 revenue of KRW 6.39 billion was roughly eight times the prior quarter's KRW 802 million. Press coverage noted that CTI revenue typically concentrates in the fourth quarter.

Annual revenue fell 29.2% to KRW 8.3 billion in 2024, and quarterly revenue has declined for three straight quarters in 2026, so the stability of the revenue stream is limited.

Theme-driven trading versus reported results

In September 2026, the share price rose more than 20% in a single session on the AI security theme, even as quarterly results remained in loss. Price moves appear to depend heavily on theme and flows, creating a gap with reported earnings. Institutional and foreign trading has also shifted alongside changes in theme interest.

10

Risk factors

Delayed earnings recovery

If Japan MNX supply and the C-Brain main-phase conversion do not reach revenue on schedule, quarterly losses could persist through 2026. Revenue declining for three straight quarters in 2026 suggests the risk is already materializing. The longer operating losses persist, the faster financial capacity could be used up.

Concentration and reliance on government projects

A large portion of SI revenue relies on the C-Brain government project, so delays in project schedules or budget execution could push back revenue recognition. CTI product sales may also concentrate on particular customers and contract structures. The more the business depends on a few contracts, the larger the quarter-to-quarter swings.

Shareholder returns and cash flow

A first cash dividend since listing was approved, but continuing payouts while earnings remain unstable depends on cash capacity. Operating cash flow once swung to -KRW 8.03 billion in 2023, showing high volatility. Whether the dividend continues will be confirmed by the resolution at the next annual shareholder meeting.

11

What to watch next

  1. End of December 2026

    Whether the C-Brain project completes its move into the main phase within 2026. Confirmation would support a larger SI revenue base than the earlier pilot phase.

  2. End of March 2027

    Filing of the 2026 annual report, which will first finalize fourth-quarter and full-year 2026 results. It is the point to check whether annual operating results close in profit or loss and how much Japan export revenue was recognized.

  3. End of March 2027

    The dividend resolution at the annual shareholder meeting. Whether the first post-listing dividend continues serves as a gauge of the company's shareholder return stance and cash capacity.

  4. Mid-May 2027

    The first-quarter 2027 report. It is the point to check whether Japan MNX revenue appears in quarterly results and whether quarterly sales spread more evenly beyond the fourth-quarter concentration.

12

Overall view

Sands LAB is a CTI specialist whose annual revenue recovered to KRW 11.6 billion in 2025, with the operating loss narrowing to KRW 1.77 billion and a return to operating profit in the fourth quarter.

However, revenue has declined for three straight quarters through the first three quarters of 2026 and operating losses continued, so a recovery in earnings is not yet confirmed.

Supportive factors include the Japan MNX export contract, the move of C-Brain into its main phase, a low debt ratio and the first dividend approved since listing.

Negative factors include concentration of revenue in the fourth quarter, continued quarterly losses, reliance on a government project and theme-driven share price moves. With no price-to-earnings ratio available, valuation rests on the price-to-book ratio and the pace of earnings recovery.

The next checkpoints are the 2026 annual report and the first-quarter 2027 report, which will show Japan revenue and whether the fourth-quarter pattern holds. This report includes no investment opinion or target price and is provided for information only.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 14 more articles and sources
  1. comp.fnguide.com
  2. alphasquare.co.kr
  3. comp.fnguide.com
  4. news.nate.com
  5. markets.hankyung.com
  6. investing.com
  7. newswell.co.kr
  8. kr.tradingview.com
  9. stockvery.com
  10. news.mtn.co.kr
  11. goinsider.kr
  12. m.news.nate.com
  13. digitaltoday.co.kr
  14. investing.com

Report written 2026-11-18 · Data as of 2026-11-17

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis